secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001193125-23-238557
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences receives Nasdaq bid price deficiency notice; 180 days to comply
--------------------------------------------------------------------------------

- Received Nasdaq notice on Sept 14, 2023 for bid price below $1.00 for 30 consecutive business days.
- Has 180 calendar days, until March 12, 2024, to regain compliance by closing bid price >= $1.00 for 10 consecutive business days.
- No immediate impact on listing or trading; may be eligible for additional 180-day compliance period if needed.
- Intends to monitor bid price and consider options, including potential reverse stock split to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523238557/0001193125-23-238557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523238557/d476127d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-238557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer